Showing results (31-40 of 421) with videos related to
Sort By:
Pageof 43
Pharmaceutical Research|September 1, 1995
Hydrophobic contribution constants of amino acid residues to the hydrophobicities of oligopeptidesH Gao, F Wang, E J LienPharmaceutical Research|August 1, 1996
Correlation of physiochemical parameters to the hydrophobic contribution constants of amino acid residues in small peptidesD Palekar, M Shiue, E J LienJournal of Drug Targeting|January 1, 1993
Hydrophobicity of oligopeptides having un-ionizable side chainsH Gao, E J Lien, F WangEuropean Journal of Pharmacology|August 1, 1977
pD2-, pA2- and pD2'-values of a series of compounds in a histaminic and a cholinergic systemF G van den Brink, E J LienAnticancer Research|September 2, 1999
Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosisP Nandy, E J Lien, V I AvramisBiochemical Pharmacology|February 1, 1988
Properties of N-hydroxy-N'-aminoguanidine derivatives as inhibitors of mammalian ribonucleotide reductaseG Weckbecker, E J Lien, J G CoryActa Oncologica (Stockholm, Sweden)|January 1, 1994
Antileukemic activity studies and cellular pharmacology of the analogues of 2-hydroxy-1H-isoindole-1,3-dione (HISD) alone and in combination with cytosine arabinoside (ara-C) against human leukemia cells CEM/0P Nandy, E J Lien, V I AvramisJournal of Medicinal Chemistry|August 1, 1985
Optimization of the Schiff bases of N-hydroxy-N'-aminoguanidine as anticancer and antiviral agentsA T'ang, E J Lien, M M LaiPharmaceutical Research|April 1, 1993
Synthesis and testing of new antileukemic Schiff bases of N-hydroxy-N'-aminoguanidine against CCRF-CEM/0 human leukemia cells in vitro and synergism studies with cytarabine (Ara-C)P B Koneru, E J Lien, V I AvramisJournal of Clinical and Hospital Pharmacy|March 1, 1983
Structure side-effect sorting of drugs. VI. OtotoxicitiesE J Lien, L R Lipsett, L L LienPageof 43